...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Circulation journal >Heart Transplantation in Asia
【24h】

Heart Transplantation in Asia

机译：亚洲心脏移植

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Heart transplantation (HTx) is the effective way to improve quality of life as well as survival in terminal heart failure (HF) patients. Since the first heart transplant in 1968 in Japan and in earnest in 1987 at Taiwan, HTx has been continuously increasing in Asia. Although the current percentage of heart transplants from Asia comprises only 5.7% of cases in the International Society of Heart and Lung Transplantation (ISHLT) registry, the values were under-reported and soon will be greatly increased. HTx in Asia shows comparable with or even better results compared with ISHLT registry data. Several endemic infections, including type B hepatitis, tuberculosis, and cytomegalovirus, are unique aspects of HTx in Asia, and need special attention in transplant care. Although cardiac allograft vasculopathy (CAV) is considered as a leading cause of death after HTx globally, multiple observations suggest less prevalence and benign nature of CAV among Asian populations. Although there are many obstacles such as religion, social taboo or legal process, Asian countries will keep overcoming obstacles and broaden the field of HTx.
机译：心脏移植（HTx）是改善终末心力衰竭（HF）患者生活质量和存活率的有效方法。自1968年在日本进行首次心脏移植，并于1987年在台湾进行了认真的移植以来，HTx在亚洲不断增长。尽管目前来自亚洲的心脏移植百分比仅占国际心脏和肺移植协会（ISHLT）登记册中病例的5.7％，但该值仍被低估，很快就会大大增加。与HTLT注册表数据相比，亚洲HTx的结果可比甚至更好。 HTx在亚洲是几种独特的感染，包括B型肝炎，结核和巨细胞病毒等地方性感染，在移植护理中需要特别注意。尽管在全球范围内，心脏同种异体移植血管病（CAV）被认为是导致HTx死亡的主要原因，但多项观察结果表明，亚洲人群中CAV的患病率和良性较低。尽管存在许多障碍，例如宗教，社会禁忌或法律程序，但亚洲国家将继续克服障碍并扩大HTx的领域。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号